Biomarkers and Cardiovascular Risk Stratification
نویسندگان
چکیده
منابع مشابه
Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification.
BACKGROUND Menopausal hormone therapy (HT) continues to have a clinical role in symptom management, but identifying women for whom benefits will outweigh the risks remains a challenge. Although hormone therapy (HT) is the most effective strategy for ameliorating vasomotor and other symptoms, randomized clinical trials show an unfavorable balance of benefits and risks for many women. However, cl...
متن کاملNovel Biomarkers for Risk Stratification and Identification of Life-threatening Cardiovascular Disease: Troponin and Beyond
Chest pain and other symptoms that may represent acute coronary syndromes (ACS) are common reasons for emergency department (ED) presentations, accounting for over six million visits annually in the United States [1]. Chest pain is the second most common ED presentation in the United States. Delays in diagnosis and inaccurate risk stratification of chest pain can result in serious morbidity and...
متن کاملCardiovascular risk stratification in familial hypercholesterolaemia
Familial hypercholesterolaemia (FH) is a common autosomal-dominant disorder in most European countries. Patients with FH are characterised by a raised level of low-density lipoprotein cholesterol and a high risk of premature coronary heart disease (CHD). Currently there is no consensus regarding the clinical utility to predict future coronary events or testing for the presence of subclinical at...
متن کاملAmbulatory blood pressure for cardiovascular risk stratification.
Ambulatory blood pressure (ABP) monitoring is increasingly recognized as a valuable tool to refine prediction of cardiovascular risk related to blood pressure (BP).1 After the first landmark study published by Perloff and colleagues 24 years ago,2 several longitudinal event-based studies provided unequivocal evidence of an independent association between ABP and risk of cardiovascular disease. ...
متن کاملCardiovascular Risk Stratification: From Phenotype to Genotype?
DOI: 10.5935/abc.20180010 Cardiovascular risk scores, such as the Framingham score, have been strongly recommended by clinical guidelines on the assessment of cardiovascular risk.1 However, several studies have shown limitations for their use,2,3 particularly in patients at intermediate risk, young patients with a definite family history, and women. Among different tools aimed at improving risk...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2019
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehz265